Ponesimod modulates the Th1/Th17/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis. Hou H, Sun Y, Miao J, Gao M, et al. J Neuroimmunol 2021;356:577583.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hou H, Sun Y, Miao J, Gao M, et al. Ponesimod modulates the Th1/Th17/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis. J Neuroimmunol 2021;356:577583.
PMID: 33940233